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A B S T R A C T
Background
Cystic fibrosis is a genetically inherited, life-threatening condition that affects major organs. The management of cystic fibrosis involves
a multi-faceted daily treatment regimen that includes airway clearance physiotherapy, taking pancreatic enzymes and othermedications.
Previous studies identified that compliance with this intensive treatment especially among adolescents with cystic fibrosis is poor.
Because of both the nature and consequences of the illness and the relentless demands of treatments, many individuals with cystic
fibrosis are likely to have a poor quality of life. Anecdotal evidence suggests that singing may provide rigorous exercises for the whole
respiratory system as well as a means for emotional expression, which may enhance quality of life.
Objectives
To evaluate the effects of a singing intervention in addition to usual therapy on the quality of life, morbidity, respiratory muscle strength
and pulmonary function of children and adults with cystic fibrosis.
Search methods
We searched the Group’s Cystic Fibrosis Trials Register, the Cochrane Central Register of Controlled Trials, major allied complementary
data bases, and clinical trial registers. Hand searching for relevant conference proceedings and journals was also carried out.
Date of search of Trials Register: 02 September 2009.
Date of additional searches: 17 September 2009.
Selection criteria
Randomised controlled trials in which singing (as an adjunctive intervention) is compared with either a sham intervention or no singing
in people with cystic fibrosis.
Data collection and analysis
No trials were found that met the selection criteria.
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Main results
No meta-analysis could be performed.
Authors’ conclusions
As no studies that met the criteria were found, this review is unable to support or refute the benefits of singing as a therapy for people
with cystic fibrosis. Future randomised controlled trials are required to evaluate singing therapy for people with cystic fibrosis.
P L A I N L A N G U A G E S U M M A R Y
The effects of singing on lung function and quality of life for children and adults with cystic fibrosis
Individuals with cystic fibrosis are at risk for respiratory infections due to too much mucus in their airways. Airway clearance is therefore
an important part of cystic fibrosis management. Increasing anecdotal evidence suggests that singing may support lung function and
enhance quality of life of people with cystic fibrosis. We searched for trials using the standard search module of the Cochrane Cystic
Fibrosis and Genetic Disorders Group, as well as extensive searches in the relevant databases and publications. We did not find any
randomised controlled trials that evaluated the benefits of singing in people with cystic fibrosis. The effects of singing in addition to
standard therapy for people with cystic fibrosis remain unknown.
B A C K G R O U N D
Description of the condition
Cystic fibrosis (CF) is a genetically inherited life-threatening con-
dition that affects major organs, such as the lungs, pancreas, liver
and kidneys. Individuals with CF produce abnormally excessive
thick mucus in the airways, which makes them more susceptible
to lung diseases. Repeated infections in the airways lead to irre-
versible lung damage (Phelan 1994).
The management of CF involves a multifaceted daily treatment
regimen that usually includes airway clearance physiotherapy,
physical exercise, taking pancreatic enzymes and other medica-
tions, as well as hospital admissions. Such an intensive treat-
ment regime may have a negative psychosocial impact on children
and adolescents (Glasscoe 2008), but particularly on adolescents
(D’Auria 2000). Previous studies identified that individuals with
CF are likely to have poor quality of life (QoL) (Quittner 2008).
Description of the intervention
Several studies have reported that people such as trained singers,
who learn diaphragmatic breathing, exhibit more efficient pul-
monary capacity than non-trained singers (Collyer 2009; Formby
1987). In people with respiratory disease, anecdotal evidence sug-
gests that adjunctive therapies that include breathing manoeuvres,
such as singing, have significant health benefits for the disease pro-
cess (Stacy 2002), as well as for psychological well being (Unwin
2002).
Singing is not merely a form of vocal expression, but also a com-
plex physical activity. Singing requires well-controlled respiratory
behaviour due to the greater range of pitch accessed during singing
compared with speaking, greater length of musical phrases than
spoken language, and the greater dynamic range used in singing
songs. To meet these artistic as well as physical challenges, singers
employ the diaphragmatic breathing method. The diaphragm as
a primary inspiratory muscle generates the necessary subglottal
pressure for singing. Louder and higher sounds are associated with
higher lung volumes (Sundberg 1987). Respiratory muscles such
as the transversus abdominis, external and internal obliques, and
the intercostals must also be fully engaged to regulate air flows
during singing. Thus, classically trained singers exhibit efficient
breath-management and greater use of their lung capacity than
non-singers (Collyer 2009; Leanderson 1988; Thomasson 1999).
Respiratory muscles also play an important role in producing ef-
fective cough, which is essential for lung health in people with
CF. For an effective cough, high subglottal pressure and strong
expiratory force are necessary (Kang 2006). For increasing one’s
ability to produce maximal expiratory pressure, it is necessary to
employ diaphragmatic breathing because it helps to increase lung
volumes and strengthen respiratory muscle capacity (Spapienza
2002; Wiens 1999).
Singing can also reduce fear, anxiety and pain perception (Kenny
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2004) and improve mood (Unwin 2002). Further, singing can
provide not only health benefits but also enjoyment. Studies found
that when singing or music was part of a breathing exercise, par-
ticipants with asthma demonstrated better treatment compliance
due to enjoyment, which enhances motivation (Fukuda 2000;
Lipawen 2000).
Additionally, a number of anecdotal reports attest to the benefits
of singing in enhancing QoL of people with lung diseases (Stacy
2002). Studies investigating the effects of a singing or music pro-
gram on the lung health and QoL of people with chronic obstruc-
tive pulmonary disorder (COPD), emphysema and asthma indi-
cate that singing can be an enjoyable, low-cost and low-risk inter-
vention, to support their lung health and enhance QoL (Engen
2005; Griggs-Drane 1999; Irons 2010; Wade 2002).
How the intervention might work
Singing as an intervention for respiratory conditions involves, in
addition to the vocal cords and laryngeal apparatus, the activation
of the muscles of the entire respiratory system through diaphrag-
matic breathing (Sundberg 1987). Diaphragmatic breathing can
increase respiratory muscle strength, which leads to increased lung
volume and effective cough (Kang 2006; Wiens 1999).
Most songs contain musical phrases of greater length than spoken
utterances, notes of various pitch, and changing dynamics (soft or
loud), which actively engage and work the respiratory muscles.
A singing intervention can be carried out in a one-to-one or group
setting in a non-judgmental and supportive environment. The
program needs to be of sufficient length and intensity to allow par-
ticipants to master the diaphragmatic breathing technique. This
can vary from individual to individual, depending on their age,
background, illness severity, past experience with singing and mu-
sic generally and the relationship between the singing facilitator
and the patient. A study of people with emphysema (over 60 years
of age) indicated that at least two half-hour sessions are necessary
for learning the diaphragmatic breathing method correctly (Engen
2005).
Why it is important to do this review
A recent Cochrane systematic review identified very few research
studies on non-medical interventions in the field of CF (Glasscoe
2008). Despite progress in medical treatment for CF, psychologi-
cal therapies to improve emotional well-being have not been forth-
coming (Elgudin 2004). To date, CF treatment has been dom-
inated by rigorous medical treatments, which are, of course, es-
sential. However, the strong emphasis on medical treatment for
CF may reflect a disease-oriented view, in which only the physical
symptoms are treated. A single medical treatment cannot provide
the care and management required to improve all dimensions of
QoL in people living with CF. A multidisciplinary treatment regi-
men can be effective in meeting the complex needs of individuals
with CF. Research in health psychology supports this view and
provides strong evidence that numerous factors influence both ill-
ness and well-being (Bernard 1994; Knight 1998). These should
be taken into account when providing a health service whose aim
is to optimise health outcomes, both medical and psycho-social.
Singing is a relatively inexpensive adjunct intervention that can
potentially enhance QoL and de-medicalise at least some of the
treatment regimens for people with CF. Thus, we have conducted
a review on the efficacy of singing as an adjunctive intervention
for people with CF to help guide clinical practice.
O B J E C T I V E S
To assess the effects of singing as an adjunctive therapy for chil-
dren and adults with CF on outcomes including QoL, morbidity,
respiratory muscles and pulmonary function.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised or quasi-randomised clinical trials.
Types of participants
People with CF, of any age, diagnosed on the basis of sweat testing
or genotype analysis.
Types of interventions
All types of singing intervention that included diaphragmatic
breathing, which were carried out in a group or one-to-one set-
ting, facilitated by singing instructors or teachers, voice coaches
or trainers, or music therapists, for a minimum of two half-hour
sessions. Studies comparing singing with a sham group that did
not involve the activation of the respiratory muscles were to be
considered. Studies using non face-to-face delivery format, such
as DVD or CD were not considered as these formats could not
address some important issues such as how to use the voice in a
healthy way while singing, and to obtain immediate feedback on
singing practice, posture and breathing technique. Further, indi-
vidual or group singing sessions can also be adjusted to the levels
of singers, which is hard to achieve through media, such as DVD
or CD.
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Types of outcome measures
Primary outcomes
1. Quality of life measured by validated instruments, e.g.
CFQ-R (Cystic Fibrosis Questionnaire-Revised), St. George’s
respiratory questionnaire, PedsQLT M (Pediatric Quality of Life
InventoryT M )
2. Respiratory muscle function
i) Maximal inspiratory flow
ii) Maximal expiratory flow
iii) Cough peak flow
Secondary outcomes
1. Other subjective scores (cough diary, Likert scales, visual
analogue scales, subjective assessment of interference of cough
etc.)
2. Spirometry
i) forced expiratory volume in one second (FEV1)
ii) forced vital capacity (FVC)
iii) forced mid-expiratory flow rate (FEF 25-75%)
3. Number of participants experiencing adverse effects of the
intervention (e.g. coughing up blood and difficulty in breathing)
4. Respiratory exacerbations
i) total number of hospitalised days
ii) total number of symptomatic days
iii) number of participants with respiratory exacerbations
5. Satisfaction with the intervention (e.g. measured by a
check-list, or post-intervention interviews)
6. Adherence to other CF treatments (e.g. measured by a
diary, self-evaluation check-list)
7. Psychological assessments measuring self-efficacy,
depression and anxiety
Search methods for identification of studies
There were no language or publication restrictions.
Electronic searches
We searched theGroup’s Cystic Fibrosis Trials Register for relevant
trials using the terms: ’cystic fibrosis’ AND ’singing’.
The Cystic Fibrosis Trials Register is compiled from electronic
searches of the Cochrane Central Register of Controlled Trials
(Clinical Trials) (updated each new issue ofThe Cochrane Library),
quarterly searches of MEDLINE, a search of EMBASE to 1995
and the prospective handsearching of two journals - Pediatric Pul-
monology and the Journal of Cystic Fibrosis. Unpublished work is
identified by searching the abstract books of three major cystic
fibrosis conferences: the International Cystic Fibrosis Conference;
the European Cystic Fibrosis Conference and theNorth American
Cystic Fibrosis Conference. For full details of all searching activi-
ties for the register, please see the relevant sections of the Cystic
Fibrosis and Genetic Disorders Group Module.
Date of search: 02 September 2009
We also searched the following sources; please see the appendices
for details of search terms and dates:
• Allied and Complementary Database AMED (1985 to
present) (Appendix 1);
• PsycINFO (1872 to present) (Appendix 2);
• CINAHL (all years) (Appendix 3);
• Dissertation Abstracts International (late 1960 to present)
(Appendix 4);
• www.clinicaltrials.gov (all years) (Appendix 5);
• Music therapy research database (all years) (Appendix 6);
• National Research Register (NRR) Archive (2000 to 2007)
(Appendix 7).
Searching other resources
We searched other relevant publications, including hand searching
of music or singing or music therapy journals.
Journal Date searched
Nordic Journal of Music Therapy (2003 - 2009 vol 18 (issue 2) 24/09/09
Australian Journal of Music Therapy (1996 - 2009 vol 20) 01/12/09
The New Zealand Journal of Music Therapy (1987 - 2005) 02/12/09
The British Journal of Music therapy (1987 - 2009) 03/12/09
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(Continued)
Musiktherapeutische Umschau (GermanMusic Therapy Journal)
(2000 - 2009)
03/12/09
Further, we have contacted experts (singing or music therapy re-
lated researchers and singing facilitators or teachers) in this area
and would have had written communication with the authors of
trials included in the review as necessary.
Data collection and analysis
We did not find any eligible studies and were unable to carry
out plans for analysis stated in the protocol. However, for future
updates, if studies are included, we will follow the methods set out
in the protocol.
Selection of studies
Twoauthors (JYI, AC) independently assessed studies for inclusion
in the review based on the inclusion criteria stated above. If there
was any disagreement in this process, they would have consulted
with the third author (DK) and resolved by discussion.
Data extraction and management
Two authors (JYI, DK) would have independently extracted data
from the eligible studies on to a standard data extraction form,
and one author (JYI) would have entered the data into RevMan
for analysis (RevMan 2008). DK would have checked the entered
data.
Trials that satisfied the inclusion criteria would have been reviewed
and the following information would have been recorded: study
setting, year of study, source of funding, participants recruitment
details (including number of eligible people), inclusion and ex-
clusion criteria, other symptoms, randomisation and allocation
concealment method, numbers of participants randomised, blind-
ing (masking) of participants, care providers and outcome asses-
sors, duration of intervention, previous singing training, co-in-
terventions, numbers of participants not followed up, reasons for
withdrawals from study protocol (clinical, side-effects, refusal and
other), details on side-effects of therapy, and whether intention-
to-treat analyses were possible. We would have extracted data on
the outcomes described previously at two points: short term (at
less than one month) and longer term (over one month and up
to six months, over six months and up to one year and annually
thereafter). We would have requested further information from
the authors where required.
Assessment of risk of bias in included studies
In order to assess the risk of bias, two review authors would have
independently assessed the quality of the studies included in the
review using the RevMan ’Risk of Bias’ table as described in Chap-
ter 8 of the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2008).
Generation of the allocation sequence
We would have graded each study for the generation of allocation
sequence as follows:
1. Low risk of bias, if methods of randomisation include using
a random number table, computer-generated lists or similar
methods;
2. Uncertain risk of bias, if the trial was described as
randomised, but no description of the methods used to allocate
participants to treatment group was described;
3. High risk of bias, if methods of randomisation include
alternation, the use of case record numbers, dates of birth or day
of the week, and any procedure that was entirely transparent
before allocation.
Allocation concealment
We would have assessed whether allocation was adequately con-
cealed, to prevent both participants and investigators from fore-
seeing assignment.
1. Adequate (low risk of bias), if the allocation of participants
involved a central independent unit, on-site locked computer,
identically appearing numbered drug bottles or containers
prepared by an independent pharmacist or investigator, or sealed
opaque envelopes;
2. Unclear (unclear risk of bias), if the method used to conceal
the allocation was not described;
3. Inadequate (high risk of bias), if the allocation sequence was
known to the investigators who assigned participants, for
example it was based on day of admission or case record number.
Blinding (or masking)
Due to the nature of the intervention, it is impossible to blind
participants. We would have assessed each study as to whether the
outcome assessors were blinded to treatment allocation (low risk
of bias); unclear whether they were blinded (unclear risk of bias);
or not blinded to treatment (high risk of bias).
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Follow up
We would have graded each study as to whether numbers of and
reasons for dropouts and withdrawals in all intervention groups
were described; or whether it was specified that there were no
dropouts or withdrawals.
1. Low risk of bias, if reasons for dropouts and withdrawals
described;
2. Uncertain risk of bias, if insufficient or selective reporting
of dropouts and withdrawals;
3. High risk of bias, if not reporting reasons for dropouts and
withdrawals likely to be related to true outcome.
Selective outcome reporting
Wewould have tried to identify and report on any selective report-
ing in the included trials, ideally by comparing the trial protocol
with the final published paper, but alternatively by comparing the
’Methods’ and ’Results’ sections of the published trial.
1. Low risk of bias, if all outcomes reported as being measured
were reported;
2. Uncertain risk of bias, if it was unclear whether all
measured outcomes were reported;
3. High risk of bias, if not all outcomes that were measured
were reported.
Other potential sources of bias
We would have tried to identify any other sources of bias not
reported elsewhere in the review and assessed their potential for
putting the trial results at risk of bias.
Measures of treatment effect
An initial qualitative comparison of all the individually analysed
studies would have examined whether pooling of results (meta-
analysis) was reasonable. This would have taken into account dif-
ferences in study populations, inclusion and exclusion criteria, in-
terventions and outcome assessment. The results from studies that
met the inclusion criteria and report any of the outcomes of in-
terest would have been included in the subsequent meta-analyses.
For the dichotomous outcome variables of each individual study,
we would have calculated the odds ratio (OR) and 95% confi-
dence intervals (CIs) using a modified intention-to-treat analysis
(modified if there are missing values due to drop outs). We would
have used the Cochrane statistical package RevMan 5.0 (RevMan
2008). Numbers needed to treat (NNT) would have been calcu-
lated from the pooled OR and its 95% CI applied to a specified
baseline risk (from the control group) using an online calculator
(Cates 2003).
For continuous outcomes we would have calculated the mean dif-
ference (MD) and 95% CIs using RevMan 5 (RevMan 2008). If
studies report outcomes using different measurement scales, the
standardised mean difference would have been estimated.
Unit of analysis issues
Cross-over trials are not appropriate for this intervention and thus
only the first arm of any cross-over trials would be included.
Dealing with missing data
The authors would have requested further information from the
primary investigators where required.
Assessment of heterogeneity
We would have described any heterogeneity between the study
results and tested this to see if it reached statistical significance
using the chi-squared test. We would have considered heterogene-
ity to be significant when the P value was less than 0.10 (Higgins
2008). We also planned to use the I² statistic, to quantify incon-
sistency of the results of the studies as described in Chapter 9 of
the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2008). We would have categorised heterogeneity such
that a value of under 25% was considered low, around 50% was
considered moderate and over 75% was considered a high degree
of heterogeneity (Higgins 2003).
Assessment of reporting biases
If combination of data and meta-analysis (with at least 10 stud-
ies) was possible, we would have assessed publication bias using a
funnel plot.
Data synthesis
We would have calculated the summary OR and mean differences
with their 95% CIs using a fixed-effect model. We would have
used a random-effects model whenever there were concerns about
statistical heterogeneity, i.e. when there was at least moderate het-
erogeneity as defined above using the I² statistic, where I² is at least
50%.
We will only combine ’other subjective scores’ (see Secondary out-
come 2) if we deem it clinically appropriate.
Subgroup analysis and investigation of heterogeneity
If there were sufficient studies included in the review and it was
appropriate, we planned the following a priori sub-group analyses:
1. Children (under 18 years old) versus adults;
2. Severity of exacerbation (based on FEV1 where over 80% is
classified as mild; 50 to 79% is classified as moderate; 30 to 49%
is classified as severe; and less than 30% is classified as very
severe);
3. Type of singing intervention (e.g. type of training, i.e.
individual or group singing, length of follow up);
4. Intervention conducted during an acute exacerbation versus
non-exacerbation state.
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Sensitivity analysis
Sensitivity analyses were also planned to assess the impact of the
potentially important factors on the overall outcomes, if there were
sufficient studies (10):
1. Variation in the inclusion criteria;
2. Risk of bias in the included studies, (particularly whether
allocation was well concealed);
3. Differences in outcome measures;
4. Analysis using random-effects model;
5. Analysis by “treatment received” or “intention-to-treat”.
R E S U L T S
Description of studies
See: Characteristics of excluded studies; Characteristics of ongoing
studies.
Results of the search
The electronic search yielded 194 studies. Initial screening of the
abstracts of these studies was undertaken by JYI and AC. A total
of 17 papers were reviewed for detailed assessment; of these, none
fulfilled the inclusion criteria and two were excluded. For details,
please see ’Characteristics of excluded studies’ below. We have
identified one ongoing study (Irons 2009).
Included studies
No study met the inclusion criteria.
Excluded studies
A music therapy study used pre-recorded music as an adjunct
to regular chest physiotherapy for toddlers with CF (under 24
months old) and their caregivers (Grasso 2000). However, singing
was not explored in this study. Another study investigated the
effects of listening to Bach’sMagnificat (a choir singing a religious
work) on 40 adults with pneumonia or acute bronchitis (Roux
2007). Singing (as opposed to listening to music) was not part of
the intervention in this study (Roux 2007).
Risk of bias in included studies
No studies were included in the review.
Effects of interventions
In the absence of any data, the effect of singing as a therapy for
people with CF remains unknown.
D I S C U S S I O N
Summary of main results
No studies could be included in this review. Two excluded studies
suggest that music may be beneficial as an adjunctive management
strategy for people with CF; however, these studies looked at the
effects of listening to music rather than actively singing. Future
research on the efficacy of a non-expensive yet potentially effec-
tive therapy on respiratory muscles and psychosocial well-being is
warranted.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is currently insufficient evidence to advocate singing as an
adjunctive therapy in the management of people with CF.
Implications for research
Previous studies have demonstrated that singing has the thera-
peutic potential to enhance the quality of life of people with
chronic respiratory disease, such as emphysema, asthma, and
COPD (Engen 2005; Griggs-Drane 1999; Irons 2010; Wade
2002). Singing, at least certain types of singing that use diaphrag-
matic breathing, can strengthen respiratory muscles. The design of
futureRCTs should include detailed information about the singing
intervention (vocal exercises, song type, pitch and dynamic range)
and delivery format (individual or group), length and frequency
of sessions and prescribed singing practice time. Trials evaluating
short-term (acute admission), medium-term (up to and including
12 months) and longer-term outcomes (over 12 months) are also
needed. Additionally, culturally appropriate musical items should
be included, taking care that different songsmake similar demands
on the respiratory and vocal systems. Dose response effects should
be assessed.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Grasso 2000 Intervention is not singing, but using pre-recorded music during chest percussion with toddlers
Roux 2007 Intervention is not singing, but listening to music; people with CF were not included
Characteristics of ongoing studies [ordered by study ID]
Irons 2009
Trial name or title The effects of singing on quality of life and lung function of children and adolescents with cystic fibrosis
Methods RCT
Participants young people between 7 and 17 years old
Interventions Individual singing session during hospital admission
Outcomes Quality of life (CFQ-R), Respiratory muscle function (maximal inspiratory flow and maximal expiratory
flow), cough peak flow, spirometry
Starting date April 2008
Contact information http://www.anzctr.org.au/trial view.aspx?ID=83944
Notes
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. AMED Search Strategy (searched on 17/09/2009)
AMED Search Strategy




5. 1 or 2 or 3 or 4
6. Sing or Singing or Singer* or Song*.tw
7. (Vocal* or breath*) adj2 exercis*.tw
8. Choir*.tw
9. Diaphragm* adj2 breath*.tw
10. 6 or 7 or 8 or 9




15. Crossover or Cross-over.tw
16. 11 or 12 or 13 or 14 or 15
16. 5 and 10 and 16
Key
tw: textword
Exp/: exploded AMED Thesaurus term
pt: publication type
Appendix 2. PsychINFO Search Strategy (searched on 17/09/2009)
PsycINFO Search Strategy
1. Cystic Fibrosis/ [PsyINFO Thesaurus Descriptor]
2. Cystic Fibrosis [keyword]
3. CF [keyword]
4. Mucoviscidosis [keyword]
5. 1 or 2 or 3 or 4
6. Sing or Singing or Singer* or Song* [keyword]
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(Continued)
7. (Vocal* or breath*) adj2 exercis*[keyword]
8. Choir*[keyword]
9. Diaphragm* adj2 breath* [keyword]
10. 6 or 7 or 8 or 9
11. Clinical trials [PsychINFO Thesaurus Descriptor]
12. Random* [keyword]
13. Placebo.tw [keyword]
14. Crossover or Cross-over [keyword]
15. 11 or 12 or 13 or 14
16. 5 and 10 and 15
Appendix 3. CINAHL Search Strategy (searched on 08/12/2009)
CINAHL Search Strategy
1. (MH “Cystic Fibrosis”) [CINAHL Subject Heading]
2. Cystic Fibrosis [all text]
3. CF [all text]
4. Mucoviscidosis [all text]
5. 1 or 2 or 3 or 4
6. Sing or Singing or Singers or Song* [all text]
7. (Vocal* or breath*) adj2 exercis* [all text]
8. Choir* [all text]
9. Diaphragm* adj2 breath* [all text]
10. 6 or 7 or 8 or 9
11. (MH “Clinical Trials+”) [Exploded CINAHL Subject heading]
12. Clinical trial [publication type]
13. Random* [all text]
14. Placebo [all text]
15. Crossover or Cross-over [all text]
16. 11 or 12 or 13 or 15
17. 5 and 10 and 16
Appendix 4. ProQuest Search Strategy: Dissertation Abstracts International (late 1960 to present)
(searched on 23/09/2009 and 24/09/2009)
ProQuest Search Strategy: Dissertation Abstracts International (late 1960 to present)
1. [as key words in citation and abstract] Cystic fibrosis
2. [as key words in citation and abstract] Cystic fibrosis AND Breathing
3. [as key words in citation and abstract] Cystic fibrosis AND Voice
4. [as key words in citation and abstract] Cystic fibrosis AND music
5. [as key words in citation and abstract] Cystic fibrosis AND singing
12Singing for children and adults with cystic fibrosis (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
6. [as key words in citation and abstract] Music therapy AND breathing
7. [as key words in citation and abstract] Singing AND breathing
8. [as key words in citation and abstract] singing OR breathing exercise AND respiratory
9. [as key words in citation and abstract] choir AND effect





Appendix 6. Music therapy research database (www.musictherapyworld.de) Search Strategy
(searched on 24/09/2009)
Music therapy research database (www.musictherapyworld.de) Search Strategy
No electronic search was possible using search terms. Thus, all abstracts were reviewed
1. Dissertations on Music Therapy (1994 - 2006)
2. Conference Reports Archive (1993 - 2001)
Appendix 7. National Research Register Archive Search Strategy (2000 - 2007)
National Research Register Archive Search Strategy
cystic fibrosis AND sing OR singing OR breathing OR choir OR vocal
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H I S T O R Y
Protocol first published: Issue 4, 2009
Review first published: Issue 5, 2010
C O N T R I B U T I O N S O F A U T H O R S
Protocol stage: draft the protocol JY Irons, A Chang, DT Kenny
Review stage: select which trials to include (2 + 1 arbiter) JY Irons, A Chang + DT Kenny
Review stage: draft the final review JY Irons, DT Kenny, A Chang
Update stage: update the review JY Irons
D E C L A R A T I O N S O F I N T E R E S T
The authors are currently conducting a single-blinded randomised controlled trial with inpatients with CF.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Music Therapy; Adolescent; Cystic Fibrosis [∗therapy]
MeSH check words
Adult; Child; Humans
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